Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside



Rating:

Share or cite this content

Citations should be made in the following way:
D. Bouros (Alexandroupolis, Greece). Stem cell therapy in IPF. International Congress 2014 – Targeting lung fibrosis: from bench to bedside

Member's Comments

No comment yet.

Related content which might interest you: Stem cell therapy in cystic fibrosis Source: Annual Congress 2004 - New approaches to cystic fibrosis: from cells and molecules to novel therapies Year: 2004 Mesenchymal stem cell therapy for severe emphysema Source: ERS Lung Science Conference 2021 Year: 2021 Mesenchymal stem cell therapy for severe emphysema Source: Virtual Congress 2021 – Repair and regeneration in chronic lung disease and lung cancer Year: 2021 Cell therapy in ILD Source: ERS Course 2016 Year: 2016 Stem cells and lung cancer Source: Eur Respir Monogr 2021; 91: 340-352 Year: 2021 Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Cell therapy for lung disease Source: Eur Respir Rev, 26 (144) 170044; 10.1183/16000617.0044-2017 Year: 2017 Cell therapy for lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Differentiation of Induced Pluripotent Stem Cells (iPSC) into human bronchial epithelium from healthy and severe COPD patients. Source: International Congress 2018 – A fresh view on airway differentiation and regeneration Year: 2018 Stem cells and lung cancer treatment: any hope? Source: International Congress 2016 – Molecular footprints in lung cancer diagnosis and management Year: 2016 Mesenchymal stem cells in aging and IPF Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 Stem cell strategies to heal/replace damaged lung tissue Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004 Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic properties Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Lung stem cells and therapy for cystic fibrosis Source: Eur Respir Monogr 2021; 91: 306-321 Year: 2021 Intratracheal application of healthy lung derived Mesenchymal Stem Cells (DON-MSC) in the form of biospheres (BS) as potential therapeutic agents for chronic lung disease Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Immunomodulatory properties of Lung Resident Mesenchymal Stem Cells in patients with COPD Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Combination therapy may be beneficial for the treatment of lymphangioleiomyomatosis Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Results immunophenotyping cultured autologous mesenchymal stromal cell of patients with COPD and IPF in Belarus Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 Cell therapy: a novel approach for the treatment of lung cancer and fibrosis Source: Annual Congress 2010 - Too close for comfort: common pathogenic mechanisms in lung cancer and fibrosis Year: 2010